Article Versions Notes

Andrieu C, McNamee N, Larkin A-M, Maguire A, Menon R, Mueller-Eisert J, Horgan N, Kennedy S, Gullo G, Crown J, et al. Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes. Medical Sciences. 2022; 10(2):26. https://doi.org/10.3390/medsci10020026

Andrieu, Charlotte, Niamh McNamee, Anne-Marie Larkin, Alanna Maguire, Roopika Menon, Judith Mueller-Eisert, Noel Horgan, Susan Kennedy, Giuseppe Gullo, John Crown, and et al. 2022. "Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes" Medical Sciences 10, no. 2: 26. https://doi.org/10.3390/medsci10020026

Andrieu, C., McNamee, N., Larkin, A.-M., Maguire, A., Menon, R., Mueller-Eisert, J., Horgan, N., Kennedy, S., Gullo, G., Crown, J., & Walsh, N. (2022). Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes. Medical Sciences, 10(2), 26. https://doi.org/10.3390/medsci10020026